Federation des caisses Desjardins du Quebec’s Direxion Daily S&P Biotech Bull 3X ETF LABU Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-15
Closed -$1.78K 2425
2023
Q2
$1.78K Hold
15
﹤0.01% 2073
2023
Q1
$1.47K Hold
15
﹤0.01% 2116
2022
Q4
$2.12K Hold
15
﹤0.01% 2198
2022
Q3
$2.1K Buy
+15
New +$2.75K ﹤0.01% 2257
2020
Q4
Sell
-5
Closed -$5.36K 2361
2020
Q3
$5.36K Buy
+5
New +$5.73K ﹤0.01% 1846

Other funds holding LABU

Federation des caisses Desjardins du Quebec's LABU Position: Q3 2023 in Review

Federation des caisses Desjardins du Quebec sold out of Direxion Daily S&P Biotech Bull 3X ETF (LABU) in Q3 2023, closing a stake of 15 shares — an estimated $1.78K sold.

Federation des caisses Desjardins du Quebec first reported a position in LABU in Q3 2020 and held it in 5 quarters. The position peaked at $5.36K in Q3 2020. 47 funds tracked by Wall St. Rank hold LABU as of Q3 2023.

  • Federation des caisses Desjardins du Quebec reported no remaining Direxion Daily S&P Biotech Bull 3X ETF position as of Q3 2023 after selling out during the quarter.
  • Federation des caisses Desjardins du Quebec sold 15 Direxion Daily S&P Biotech Bull 3X ETF shares in Q3 2023, an estimated $1.78K.
  • Federation des caisses Desjardins du Quebec first reported a position in Direxion Daily S&P Biotech Bull 3X ETF in Q3 2020 and held it in 5 quarters.
  • Federation des caisses Desjardins du Quebec's Direxion Daily S&P Biotech Bull 3X ETF position peaked at $5.36K in Q3 2020.
  • 47 funds tracked by Wall St. Rank held Direxion Daily S&P Biotech Bull 3X ETF as of Q3 2023.

Based on Federation des caisses Desjardins du Quebec's 13F filing for Q3 2023, filed 15 Aug 2024.